Block 1 Part 2 Flashcards

1
Q

hormone CCK

A

cholesytokinin - produced by intestine when it senses FA - releases bile (amphipathic form of cholesterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

secretin

A

hormone that stimulates pancreatic release of bicarbonate to neutralize stomach acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

orlistat

A

drug that inhibits all lipases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

enzymes involved in fat metabolism

A
cholesterol esterase (cholesterol ester to cholesterol); phospholipase A2 (removes last fatty acid on triglyceride - usually sn2 position)
lipase/co-lipase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

function of enterocytes in TG metabolism

A

uptake, re-esterify FA and cholesterol –>chylomicrons (carry ApoB48) travel through lymph to blood, transporting triglycerides to adipose, muscle, and heart cells
Blood LPL rips off free FA from chylomicron—>FA to cells, leaving chylomicron remnants. Liver converts depleted chylomicron remnants into lipoproteins VLDL, uptakes LDL, secretes HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FA Synthesis

A

add 2C/cycle (requires transport into cytoplasm) Key players: mitochondrial ACC (acetyl CoA carboxylase, +biotin), cytosolic FA synthase (+biotin), Malate-Citrate Shuttle (transport from mt—>ct) 1. Mitochondria: Acetyl CoA+CO2—>malonyl CoA (via ACC) 2. Malate-Citrate shuttle: transports malonyl CoA from mitochondria into cytoplasm (citrate vs pyruvate transporter) 3. Cytoplasm: malonyl coA+acyl carrier+Acetyl CoA—> Palmitate (via FA synthase) *Each round adds 2C (from Acetyl CoA), generating Palmitate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

enzymes involved in FA synthesis

A

acetyl coA carboxylase (ACC: acetyl coA -> malonyl coA)
malate-citrate shuttle
FA synthase (BIOTIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hormonal regulation of FA synthesis

A

insulin: activates phosphatase that activates ACC

glucagon/epinephrin: activate cAMP-dependent PKA - inactivates ACC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

main enzymes involved in FA metabolism

A
  1. FA caA synthethase (outer membrane of mitochondria - “activates” FA by making FA coA it can now move into IM space)
  2. CPT1 (carnitine palmitoyl transferase - makes FAcarnitine that can move into matrix)
  3. CPTII (makes FA coA and carnitine in matrix)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

beta oxidation

A

oxidize to double bond between alpha and beta; ox to hydroxyl; ox to carbonyl; thiolysis by coA –> FADH2, NADH2, acetyl coA
MCAD - medium chain acetyl dehydrogenase (makes a-b double bond)
LCAD - long chain …

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hormonal regulation of beta ox

A
  1. insulin –> phosphatase –> ACC –> malonyl coA –| CPT1 –| beta ox
  2. glucagon/epinephrin –> PKA –| ACC – low levels of malonyl coA –> CPT1 active –> beta ox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ketone bodies

A

acetoacetate, beta hydroxybutyrate, acetone.
acetyl coA cannot enter TCA b/c oxaloacetate is depleted (used up in gluconeogenesis)
liver cannot use ketone bodies that well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MCADD

A

cannot reduce medium chain FAs into acyl CoA for beta oxidation
Labs: low ketones* (minimal ketones made), low glucose, accumulation of C8-acylcarnitine (confirm with mass spec, enzyme assay) *can still make minimal ketones (vs LCADD)
Clinical presentation: baby not fed overnight, presents with seizure in the AM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LCADD

A

can’t breakdown long chain FA into acyl CoA for beta oxidation
Labs: low glucose, NO ketones*, brown urine (rhabdomyolysis), accumulation of long chain FA (mass spec), confirm with enzyme assay *LC FA require LCAD for any beta oxidation/ketone generation
Clinical presentation: child with minor URI triggers crisis with fever, low PO intake, progressive sleepiness and difficult to arouse
FAOD Treatment: start high glucose ASAP, avoid fasting for >8- 12h, carnitine supplementation (maximize transport into mitochondria)
(muscle uses long chain; liver medium chain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

rhabdomyolysis

A

muscle breakdown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HMG coA reductase

A

enzyme for cholesterol synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ACAT

A

converts free cholesterol in cytosol to lipid droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LDL uptake consequences

A

uptake by LDLR –> (-) HMG coA reductase activity; (+) ACAT activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

statins

A

inhibit HMGcoA reductase –> low intracellular cholesterol–> SRBP2 on –> (+) LDLR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

SREBP Pathway

A

(+) LDLR and HMG coAR –> (-) plasma LDL; (+) Insig (inactivates SREBP = negative feedback)
activated by low cholesterol and insulin

low cholesterol -> SREBP activated, docked by SCAP; transported to golgi, cleaved by S1P (membrane protein) and S2P. high cholesterol -> cholesterol binds to SCAP and Insig

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LXR-RXR

A

transcription factor that increases enzymes important for excreting cholesterol; increase bile salt formation; activates SREBP1
activated by high cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PCSK9 inhibitors

A

when used w statin massively increase LDLR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

arachidonic acid

A

used by the body to synthesize 20C FA and 5member ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how NH3+ travels in the blood

A

alanine, glutamate, glutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
ALT
alanine amino acid transaminase (liver; if in the blood evidence of liver damage)
26
enzyme defective in PKU
phenylalanine hydroxylase (phenylalanine to tyrosine; uses tetrahydrobiopterin and NDAH)
27
toxic side product that accumulates PKU
phenylpyruvate ("substrate excess")
28
clinical presentation PKU
cognitive disorder light color skin mousey smell
29
screening for PKU
guthrie test (bacterial growth in response to blood); urine; mass spec
30
treatment for PKU
diet; KUVAN = tetrahydrobiopterin
31
pneumonic for phenylalanine pathway
find yourself hiking high mountains for fun alone (phenyalanine, tyrosine, hydroxyphenylpyruvate, homogentase, maleylacetoacetate, fumarylacetoacetate, fumarate+acetoacetyl-coA)
32
tyrosinemia I
succinylacetone (from all the fumarylacetoacetate) acumulates. enzyme: fumarylacetoacetase. symptoms: liver failure, bilirubin, no coagulation factors, edema, anemia (heme producing protein blocked by succinylactone) blood tyrosine and methonine; succinyllactone in urine. treatment: NTBC = inhibitor of hydroxyphenylpyruvate dioxygenase
33
MSUD
mitochondrial BCKD (branched chain keto acid dehydrogenase) is defective. keto acid derivative excreted in urine smells like maple syrup. pt is acidotic. AR. neuronal defects, ataxia, poorly responsive, coma, seizures; attacks brought on by other illnesses (catabolic activity turned on)
34
homocystinuria
enzyme defective: CBS (homocysteine cannot be turned into cystathionine, precursor of cysteine). homocysteine and methionine accumulate. tall posture, scoliosis, learning abnormalities, clotting disorder --> strokes/infarctions; lens of eye dislocates. diagnosis: urine homocysteine sky high. diet
35
diazoxide
inhibits K channel closure --> cell remains hyperpolarized --> Ca influx is inhibited --> insulin not released
36
OTC deficiency
urea cycle defect carbamoul phosphate generates orotic acid instead of citrulline XR presentation: lethargy, seizure; high NH3 levels. Note: steroids, trauma, weight loss --> can trigger excess NH3 and disease manifestation treatment: dialysis; scavenger theraphy w benzoic acid or phenylbutyrate
37
arginosuccinate lyase deficienty
urea cycle defect
38
HSP 70, HSP60
heat proteins/chaperons - refold proteins inside mitochondria
39
3 common "metabolite imbalances" in mitochondrial diseases
1. high pyruvate 2. high lactate 3. NADH > NAD+
40
mitochondrial complex encoded by nDNA
complex II (succinate dehydrogenase) --> part of the TCA cycle
41
electron path in mitochondria
CoQ - III - cytochrome C - IV cytochrome oxidase (H2O is created here; cyanide sensitive step)
42
1. heteroplasty 2. threshold effect 3. mitotic segregation
1. mitochondrial genes are different from one another 2. pt is fine w up to 70-80% gene defect 3. daughter cells might have more or less defective mitochondria
43
kinesin
motor protein towards (+) = synapse
44
dynein
motor protein away from synapse
45
Miro and Milton
``` adaptor proteins (GTPases). microtubule --> kinesin motor --> miro and milton --> mitochondria ```
46
Charcot-Marie-Tooth
AD. mitochondrial protein Mfn2 (fusogenic protein in the outer membrane *works by dimerizing) defective. nDNA. long nerves affected -- muscle weakness, gait disturbances. CMTI worse than CMTII
47
Optic Atrophy Gene
AD. mitochondrial protein OPA1 (fusogenic protein in the inner membrane*works by dimerizing) defective. nDNA. vision loss, ophtalmoplegia
48
protein involved in mitochondrial fission
dynamin
49
ptosis
drooping eye lids
50
Kerns-Searns (KSS)
mitochondrial disease large deletion of mDNA and tRNA genes. muscle biopsy = ragged red fibers. cytochrome oxidase missing. anemia (can disappear); ptosis; low weight
51
NARP (Neuropahty Ataxia Reinitis Pigmentosa) | MILS (Maternal Inherited Leigh Syndrome)
2 mitochondrial diseases that can be caused by same mutation. heteroplasty results in phenotypic variations. NARP (70-90% mtDNA mutation). MILS (>90% mutation)
52
MNGIE
mitochondrial disease. thymine phosphorylase defective --> thymidine accumulates -->imbalance of nucleosides --> mDNA instability and loss. affects GI neurons --> diarrhea one of the first signs of disease
53
Nucleic acid salvage pathway
Ribose-1-P=>ribose-5-P=>5-phosphoribosyl-1-pyrophosphate (PRPP). --> add new bases A and G and Hypoxanthine to reform the Purine Nucleotides
54
De Novo nucleic acid pathway
start w adding NH3 to 5-PRPP. ring build w aa doming NH3 and multiple C donors (glycine, CO2, C=O ). Result: inosine monophosphate
55
IMP
inosine monophosphate. product of de novo nuc acid synthesis. source of GMP (imp oxidized to xanthine, nitrosylated by glutamine) and AMP
56
pyrimidine de novo pathway
create base first then ligate to sugar (vs. purine - build base at 5PRPP)
57
gout
too much uric acid --> kidney stones, gouty arthritis. diagnosis: xray shadow, milky joint fluid. treatment; rasburicase (enzyme), allopurinol (competitor inhibitor that binds to xanthine oxidase)
58
Lesh-Nyhan
X linked defect in HGPRT (rescues hypoxanthine and guanine to produce GMP and IMP). way too much uric acid. gout, self mutilation, failure to walk, communicate. treatment: restrict aa consumption
59
phosphoribosyl pyrophosphate synthetase superactivity
similar to Lesh-Nyhan - defect in enzyme causes gout, etc
60
SCID
severe combined immunodeficiency: adenoside deaminase deficiency (adenosine --> inosine). adenosine accumulates and forms dATP -> inhibits proliferation of immune cells. repetitive infections. enzyme replacement, bone marrow transplant
61
probenecid
drug for chronic treatment of gout; blocks transport of uric acid from kidney to blood